Recent Advances in Methodologies for the Discovery of Antimycobacterial Drugs

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Current Bioactive Compounds

• Publication date

  2007-08-31

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.2174/157340707781695550
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• 2-Amino-5,7-dimethyl-1,8-naphthyridine as a fluorescent reagent for the determination of nitrite.

  2007cited by this paper
• Towards establishing a method to screen for inhibitors of essential genes in mycobacteria: evaluation of the acetamidase promoter.

  2006cited by this paper
• Current Perspectives on Drug Susceptibility Testing of Mycobacterium tuberculosis Complex: the Automated Nonradiometric Systems

  2006cited by this paper
• Design, Synthesis, and SAR Studies of Mefloquine‐Based Ligands as Potential Antituberculosis Agents

  2006cited by this paper
• Evaluation of a modified antimycobacterial susceptibility test using Middlebrook 7H10 agar containing 2,3-diphenyl-5-thienyl-(2)-tetrazolium chloride.

  2006cited by this paper
• Rapid Microbiologic and Pharmacologic Evaluation of Experimental Compounds against Mycobacterium tuberculosis

  2006cited by this paper
• Multicenter Laboratory Validation of the BACTEC MGIT 960 Technique for Testing Susceptibilities of Mycobacterium tuberculosis to Classical Second-Line Drugs and Newer Antimicrobials

  2006cited by this paper
• Mycobacteria in drinking water distribution systems: ecology and significance for human health.

  2005cited by this paper
• A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis

  2005cited by this paper
• Rapid Detection of Ofloxacin Resistance in Mycobacterium tuberculosis by Two Low-Cost Colorimetric Methods: Resazurin and Nitrate Reductase Assays

  2005cited by this paper
• Rapid, inexpensive MIC determination of Mycobacterium tuberculosis isolates by using microplate nitrate reductase assay.

  2005cited by this paper
• Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.

  2005cited by this paper
• New perspectives on natural products in TB drug research.

  2005cited by this paper
• Changes in energy metabolism of Mycobacterium tuberculosis in mouse lung and under in vitro conditions affecting aerobic respiration

  2005cited by this paper
• Evaluación de métodos fenotípicos y genotípicos para la detección de farmacorresistencia de Mycobacterium tuberculosis.

  2005cited by this paper
• Comparative evaluation of the nitrate reduction assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis.

  2005cited by this paper
• The magic bullets and tuberculosis drug targets.

  2005cited by this paper
• [Phenotypic and genotypic methods for detecting multidrug resistance in Mycobacterium tuberculosis].

  2005cited by this paper
• Acetophenones with selective antimycobacterial activity

  2005cited by this paper
• Drug-susceptibility testing in tuberculosis: methods and reliability of results

  2005cited by this paper
• Mycobacterium avium enters a state of metabolic dormancy in response to starvation.

  2005cited by this paper
• Preclinical Testing of the Nitroimidazopyran PA-824 for Activity against Mycobacterium tuberculosis in a Series of In Vitro and In Vivo Models

  2005cited by this paper
• Regulation of nitrate reductase activity in Mycobacterium tuberculosis by oxygen and nitric oxide.

  2005cited by this paper
• mmpL7 Gene of Mycobacterium tuberculosis Is Responsible for Isoniazid Efflux in Mycobacterium smegmatis

  2005cited by this paper
• Mycobacterium avium Complex Pulmonary Disease in Immunocompetent Patients

  2005cited by this paper
• Microplate nitrate reductase assay versus Alamar Blue assay for MIC determination of Mycobacterium tuberculosis.

  2005cited by this paper
• Safe susceptibility testing of Mycobacterium tuberculosis by flow cytometry with the fluorescent nucleic acid stain SYTO 16.

  2005cited by this paper
• Bacterial luciferase is naturally destabilized in Mycobacterium tuberculosis and can be used to monitor changes in gene expression.

  2005influential reference
• Infection with the Mycobacterium avium complex in patients without predisposing conditions: a case report and literature review.

  2005cited by this paper
• Comparison of BACTEC MGIT 960 system and BACTEC 460 TB system for growth and detection of Mycobacteria from clinical specimens.

  2004cited by this paper
• Multicenter Evaluation of the MB/BACT System for Susceptibility Testing of Mycobacterium tuberculosis

  2004cited by this paper
• Anaerobic incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis.

  2004cited by this paper
• A Promoter Mutation Causes Differential Nitrate Reductase Activity of Mycobacterium tuberculosis and Mycobacterium bovis

  2004cited by this paper
• Quinones as antimycobacterial agents.

  2004cited by this paper
• Detection of Viable Mycobacterium avium Subsp. Paratuberculosis Using Luciferase Reporter Systems

  2004cited by this paper
• Present status and future prospects of chemotherapeutics for intractable infections due to Mycobacterium avium complex.

  2004cited by this paper
• Evaluation of microplate Alamar blue assay for drug susceptibility testing of Mycobacterium avium complex isolates.

  2004cited by this paper
• Health Impacts of Environmental Mycobacteria

  2004cited by this paper
• Identification and validation of novel drug targets in tuberculosis.

  2004cited by this paper
• Bacteriological follow-up of pulmonary tuberculosis treatment: a study with a simple colorimetric assay.

  2004cited by this paper
• The Mycobacterium tuberculosis complex transcriptome of attenuation.

  2004cited by this paper
• Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study.

  2004cited by this paper
• Natural antimycobacterial metabolites: current status.

  2004cited by this paper
• Gene expression profile of Mycobacterium tuberculosis in a non-replicating state.

  2004cited by this paper
• Structural bioinformatic approaches to the discovery of new antimycobacterial drugs.

  2004cited by this paper
• Application of Oxidation-Reduction Assay for Monitoring Treatment of Patients with Pulmonary Tuberculosis

  2004cited by this paper
• Development of a new fluorescent probe: 1,3,5,7-tetramethyl-8-(4'-aminophenyl)-4,4-difluoro-4-bora-3a,4a-diaza-s-indacence for the determination of trace nitrite.

  2004cited by this paper
• Drug susceptibility testing of Mycobacterium tuberculosis with nitrate reductase assay.

  2004cited by this paper
• The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biology.

  2003cited by this paper
• Comparison of the susceptibility testing of clinical isolates of Mycobacterium tuberculosis by the XTT colorimetric method and the NCCLS standards method.

  2003cited by this paper
• Resazurin Microtiter Assay Plate Testing of Mycobacterium tuberculosis Susceptibilities to Second-Line Drugs: Rapid, Simple, and Inexpensive Method

  2003cited by this paper
• Improved Green Fluorescent Protein Reporter Gene-Based Microplate Screening for Antituberculosis Compounds by Utilizing an Acetamidase Promoter

  2003cited by this paper
• Decolorization of Malachite Green and Crystal Violet by Waterborne Pathogenic Mycobacteria

  2003cited by this paper
• The 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) assay as rapid colorimetric method for determination of antibiotic susceptibility of clinical Mycobacterium tuberculosis isolates in liquid medium.

  2003cited by this paper
• Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid.

  2003cited by this paper
• Use of Receiver Operating Characteristic Curves to Assess the Performance of a Microdilution Assay for Determination of Drug Susceptibility of Clinical Isolates of Mycobacterium tuberculosis

  2003cited by this paper
• Tuberculosis. Advances in laboratory diagnosis and drug susceptibility testing.

  2002cited by this paper
• Resazurin Microtiter Assay Plate: Simple and Inexpensive Method for Detection of Drug Resistance in Mycobacterium tuberculosis

  2002cited by this paper
• Infection and disease caused by environmental mycobacteria

  2002cited by this paper
• Tetrazolium Microplate Assay as a Rapid and Inexpensive Colorimetric Method for Determination of Antibiotic Susceptibility of Mycobacterium tuberculosis

  2002cited by this paper
• Antimycobacterial activity of 4'-bromo-[1,1'-biphenyl]-4-yl 4-x-phenylmethanone derivatives, and their acute toxicity and cytotoxicity.

  2001cited by this paper
• Comparison of Two Rapid Colorimetric Methods for Determining Resistance of Mycobacterium tuberculosis to Rifampin, Isoniazid, and Streptomycin in Liquid Medium

  2001cited by this paper
• Plate-based dormancy culture system for Mycobacterium smegmatis and isolation of metronidazole-resistant mutants.

  2001cited by this paper
• A rapid, microplate-based assay for evaluating the activity of drugs against Mycobacterium leprae, employing the reduction of Alamar Blue.

  2000cited by this paper
• Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity.

  2000influential reference
• Two Liquid Medium Systems, Mycobacteria Growth Indicator Tube and MB Redox Tube, for Mycobacterium tuberculosis Isolation from Sputum Specimens

  2000cited by this paper
• Analysis of the dormancy-inducible narK2 promoter in Mycobacterium bovis BCG.

  2000influential reference
• A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis

  2000cited by this paper
• Bioluminescent Mycobacterium aurum expressing firefly luciferase for rapid and high throughput screening of antimycobacterial drugs in vitro and in infected macrophages.

  2000cited by this paper
• Metronidazole Therapy in Mice Infected with Tuberculosis

  1999cited by this paper
• Evaluation of the New MB Redox System for Detection of Growth of Mycobacteria

  1999cited by this paper
• Genomic Analysis Reveals Variation between Mycobacterium tuberculosis H37Rv and the Attenuated M. tuberculosis H37Ra Strain

  1999cited by this paper
• Role of Acid pH and Deficient Efflux of Pyrazinoic Acid in Unique Susceptibility of Mycobacterium tuberculosis to Pyrazinamide

  1999cited by this paper
• Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates.

  1999cited by this paper
• Comparison of a Nonradiometric Liquid-Medium Method (MB REDOX) with the BACTEC System for Growth and Identification of Mycobacteria in Clinical Specimens

  1999cited by this paper
• Fluorescence-based detection of lacZ reporter gene expression in intact and viable bacteria including Mycobacterium species.

  1999cited by this paper
• Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

  1998cited by this paper
• Change in colony morphology influences the virulence as well as the biochemical properties of the Mycobacterium avium complex.

  1998cited by this paper
• Genetic rearrangements leading to disruption of heterologous gene expression in mycobacteria: an observation with Escherichia coli beta-galactosidase in Mycobacterium smegmatis and its implication in vaccine development.

  1998cited by this paper
• Rapid, Low-Technology MIC Determination with Clinical Mycobacterium tuberculosis Isolates by Using the Microplate Alamar Blue Assay

  1998cited by this paper
• Green fluorescent protein as a reporter in rapid screening of antituberculosis compounds in vitro and in macrophages.

  1998cited by this paper
• Action of metronidazole in combination with isoniazid & rifampicin on persisting organisms in experimental murine tuberculosis.

  1998cited by this paper
• Metronidazole has no antibacterial effect in Cornell model murine tuberculosis.

  1998cited by this paper
• Green Fluorescent Protein as a Reporter in Rapid Screening of Antituberculosis Compoundsin Vitroand in Macrophages

  1998cited by this paper
• RecombinantMycobacterium aurumExpressingEscherichia coliβ-Galactosidase in High Throughput Screening of Antituberculosis Drugs

  1997cited by this paper
• beta-Galactosidase reporter system in mycobacteria and its application in rapid antimycobacterial drug screening.

  1997cited by this paper
• Recombinant Mycobacterium aurum expressing Escherichia coli beta-galactosidase in high throughput screening of antituberculosis drugs.

  1997cited by this paper
• Rapid screening of natural products for antimycobacterial activity by using luciferase-expressing strains of Mycobacterium bovis BCG and Mycobacterium intracellulare

  1997cited by this paper
• Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium

  1997cited by this paper
• Identification of mycobacteria by conventional methods.

  1996cited by this paper
• Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery

  1996cited by this paper
• [Determination of antimycobacterial activities of fluoroquinolones against clinical isolates of Mycobacterium tuberculosis: comparative determination with egg-based Ogawa and agar-based Middlebrook 7H10 media].

  1996cited by this paper
• Relationship between virulence of Mycobacterium avium strains and induction of tumor necrosis factor alpha production in infected mice and in in vitro-cultured mouse macrophages

  1995cited by this paper
• Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis

  1994cited by this paper
• Characterization of the virulence of Mycobacterium avium complex (MAC) isolates in mice

  1994cited by this paper
• Infection with Mycobacterium avium complex in patients without predisposing conditions.

  1989cited by this paper
• In vitro and in vivo activities of clarithromycin against Mycobacterium avium

  1989cited by this paper
• Utilization of nitrate or nitrite as single nitrogen source by Mycobacterium avium

  1987cited by this paper
• [Studies on early detection of mycobacterial growth by application of STC (2,3-diphenyl-5-thienyl-(2)-tetrazolium chloride). 3. Study on STC-containing media].

  1972cited by this paper

• Quantifying uncertainty of tuberculosis drug susceptibility range from single-microplate test

  2026cites this paper
• Thiourea compounds as multifaceted bioactive agents in medicinal chemistry.

  2025cites this paper
• Probes and techniques used in active and the hypoxia-based dormant state of an antitubercular drug screening assay

  2021cites this paper
• Novel Antitubercular Derivatives of Mannich and Schiff Bases of p-Aminosalicylic Acid – Rational Design

  2021cites this paper
• The Application of Multiplate Resazurin Reduction Assay in The Screening for Anti-Mycobacterial Activity from Indonesian Medicinal Plants

  2019cites this paper
• The potency of Pinus merkusii extract nanoparticles as anti Mycobacterium tuberculosis: An in vitro study

  2019cites this paper
• Investigation of antibiotic targets in the decaprenyl-phosphorylarabinose biosynthesis in m. tuberculosis

  2019cites this paper
• Bioassay-guided isolation of an antimycobacterial compound from Leonurus japonicus Houtt

  2019cites this paper
• Polyketide Synthase–Nonribosomal Peptide Synthetase Hybrid Enzymes of Fungi

  2018cites this paper
• Evaluation of antimycobacterial activity of Curcuma xanthorrhiza ethanolic extract against Mycobacterium tuberculosis H37Rv in vitro

  2018cites this paper
• Evaluation of antimycobacterial, leishmanicidal and antibacterial activity of three medicinal orchids of Arunachal Pradesh, India

  2017cites this paper
• In vitro Antibacterial Activity of Chitosan Nanoparticles against Mycobacterium tuberculosis

  2017cites this paper
• Palladium(II)/N,N-disubstituted-N′-acylthioureas complexes as anti-Mycobacterium tuberculosis and anti-Trypanosoma cruzi agents

  2017cites this paper
• MICROWAVE IRRADIATED SYNTHESIS, BIOLOGICAL EVALUATION AND MOLECULAR DOCKING STUDIES OF 3-((SUBSTITUTED-BENZO[D]THIAZOL-2-YLAMINO)METHYL)-5- (PYRIDIN-4-YL)-1,3,4-OXADIAZOLE-2(3H)-THIONE

  2017cites this paper
• Natural Compounds from Mexican Medicinal Plants as Potential Drug Leads for Anti-Tuberculosis Drugs.

  2017cites this paper
• Design, synthesis, characterization and biological evaluation of some novel heterocyclic compounds as anti-tubercular agents.

  2016cites this paper
• Nanomedicines for the treatment of tuberculosis

  2016cites this paper
• Design, Synthesis, Characterization and Biological Evalution of Some Novel Heterocyclic Derivatives as Anti - Tubercular Agents

  2016cites this paper
• Chapter 32 – Antimicobacterial Drugs

  2016cites this paper
• Metabolitos secundarios de Clusiaceae y Julianaceae con actividad contra Mycobacterium tuberculosis y el virus de inmunodeficiencia humana tipo 1 (VIH-1)

  2015cites this paper
• Carbon-14 radiolabeling and in vivo biodistribution of a potential anti-TB compound.

  2015cites this paper
• In vitro antimycobacterial activity of six Cameroonian medicinal plants using microplate alamarBlue assay.

  2015cites this paper
• Synthesis , Characterization & Evaluation of Some Novel Pyrazoline Derivatives as Anti-Tuberculosis Agents

  2015influential citation
• Cracking the resistance of non-tuberculosis mycobacterium against existing antibiotics

  2015influential citation
• A High-Throughput Cidality Screen for Mycobacterium Tuberculosis

  2015cites this paper
• The in vitro evaluation of ortho-/meta-/para-alkoxyphenylcarbamic acid esters containing 4-(4-fluorophenyl)piperazin-1-yl moiety against Mycobacterium tuberculosis H37Ra strain.

  2014cites this paper
• Optimisation of the microplate resazurin assay for screening and bioassay-guided fractionation of phytochemical extracts against Mycobacterium tuberculosis.

  2014cites this paper
• Killed but metabolically active Mycobacterium bovis bacillus Calmette-Guérin retains the antitumor ability of live bacillus Calmette-Guérin.

  2014cites this paper
• New class of methyl tetrazole based hybrid of (Z)-5-benzylidene-2-(piperazin-1-yl)thiazol-4(%H)-one as potent antitubercular agents.

  2014cites this paper
• Peripheral mitochondrial function in multiple organ dysfunction syndrome

  2014cites this paper
• Double Recombinant Mycobacterium bovis BCG Strain for Screening of Primary and Rationale-Based Antimycobacterial Compounds

  2013cites this paper
• Transcriptome Analysis Reveals Novel Entry Mechanisms and a Central Role of SRC in Host Defense during High Multiplicity Mycobacterial Infection

  2013cites this paper
• In vitro Anti-mycobacterial activity of selected medicinal plants against Mycobacterium tuberculosis and Mycobacterium bovis Strains

  2013cites this paper
• One pot synthesis of some novel coumarins containing 5-(substituted-2-hydroxybenzoyl) pyridine as a new class of antimicrobial and antituberculosis agents

  2013cites this paper
• Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis.

  2012cites this paper
• The acute bacterial toxicity of the selenocyanate anion and the bioprocessing of selenium by bacterial cells

  2012cites this paper
• Busca de fitofármacos com potencial atividade contra Mycobacterium tuberculosis a partir de óleos essenciais

  2012cites this paper
• THE BACTERIAL TOXICITY OF SELENOCYANATE AND THE INCORPORATION OF TELLURIUM AND SELENIUM IN BACTERIAL CELLS, AND THE SYNTHESIS AND BIOSYNTHESIS OF CADMIUM TELLURIDE NANOPARTICLES AND THEIR ELEMENTAL QUANTIFICATION VIA ICP-AES

  2012cites this paper
• Copper-Boosting Compounds: a Novel Concept for Antimycobacterial Drug Discovery

  2012cites this paper
• Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence

  2011cites this paper
• ADMEt Evaluation of Anti-tuberculosis Compounds and New Methodologies Development

  2011cites this paper
• Ruthenium (II) phosphine/picolinate complexes as antimycobacterial agents.

  2010cites this paper
• Thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide/hydrazones: anti-Mycobacterium tuberculosis activity and cytotoxicity.

  2010cites this paper
• ATIVIDADE ANTI - Mycobacterium tuberculosis INTRA E EXTRACELULAR E CITOXICIDADE DOS COMPLEXOS DE RUTÊNIO E VANÁDIO E SEUS LIGANTES

  2009cites this paper